Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients (ACTIV)

September 6, 2023 updated by: Tamara Kriukova, Eurasian Association of Therapists
Non-commercial depersonalized multi-centered registry study on analysis of chronic non-infectious diseases dynamics after SARS-CoV-2 infection in adults.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Non-commercial depersonalized multi-centered registry study on analysis of chronic non-infectious diseases dynamics after SARS-CoV-2 infection in cohort of Russian adult patients.

Retrospective analysis of medical histories and outcomes in adults with pre-existing conditions after SARS-CoV-2 infection and prospective monitoring of health status during 3, 6 and 12 months after discharge. Comorbidities worsening risk factors measuring through evaluation of range of indicators such as dynamics of diabetes, CKD, COPD, bronchial astma, incidence of hypertonic crises, vascular events and others.

Study Type

Observational

Enrollment (Actual)

6396

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Russian Federation
      • Moscow, Russian Federation, 101000
        • Eurasian Association of Therapists

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Sampling Method

Probability Sample

Study Population

Anonymized male and female patients over 18 years infected COVID-19 recieved inpatient or outpatient care

Description

Inclusion Criteria:

  • Suspected or confirmed COVID-19.

Exclusion Criteria:

  • Refuse to be involved in study;
  • Age under 18 years.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
inpatients
Patients treated from COVID-19 in hospital
Other: non-interventional
Interview on health conditions
outpatients
Patients treated from COVID-19 at home
Other: non-interventional
Interview on health conditions

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
rate of non-infectious diseases
Time Frame: 12 month since a moment of request of medical help
percentage of patients with non-infectious diseases relating to overall number of patients registered in study
12 month since a moment of request of medical help
severity of COVID-19 depending on pre-existing diseases
Time Frame: 12 month since a moment of request of medical help
correlation between number of patients with COVID-19 of various severity and number of pre-existing conditions and their severity among these groups
12 month since a moment of request of medical help
disability registration / change of disability status
Time Frame: 12 month since a moment of request of medical help
Registration of disability or change of disability status
12 month since a moment of request of medical help
rate of letal outcomes
Time Frame: 12 month since a moment of request of medical help
rate of deaths among registered participants
12 month since a moment of request of medical help
rate of letal outcomes depending on pre-existing disease
Time Frame: 12 month since a moment of request of medical help
correlation between number of deaths and pre-existing diseases
12 month since a moment of request of medical help

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Eurasian Association of Therapists

Investigators

  • Study Chair: Alexander Arutyunov, professor, Eurasian Association of Therapists

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 29, 2020

Primary Completion (Actual)

November 29, 2020

Study Completion (Actual)

November 29, 2021

Study Registration Dates

First Submitted

July 27, 2020

First Submitted That Met QC Criteria

July 29, 2020

First Posted (Actual)

July 30, 2020

Study Record Updates

Last Update Posted (Actual)

September 8, 2023

Last Update Submitted That Met QC Criteria

September 6, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • ACTIV11062020

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiovascular Diseases

Clinical Trials on non-interventional

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Finland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe